Albemarle to divest Ketjen control, Eurecat stake in $660 million deal
PositiveFinancial Markets

Albemarle Corporation is making a significant move by divesting its control over Ketjen and its stake in Eurecat in a deal valued at $660 million. This strategic decision reflects Albemarle's focus on optimizing its portfolio and enhancing its core business operations. Such divestitures can lead to increased efficiency and allow the company to concentrate on its most profitable segments, which is crucial in today's competitive market.
— Curated by the World Pulse Now AI Editorial System












